Abstract

Cardiovascular diseases (CVDs) are of multifactorial origin and can be attributed to several genetic and environmental components. CVDs are the leading cause of mortality worldwide and they primarily damage the heart and the vascular system. Non-coding RNA (ncRNA) refers to functional RNA molecules, which have been transcribed into DNA but do not further get translated into proteins. Recent transcriptomic studies have identified the presence of thousands of ncRNA molecules across species. In humans, less than 2% of the total genome represents the protein-coding genes. While the role of many ncRNAs is yet to be ascertained, some long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have been associated with disease progression, serving as useful diagnostic and prognostic biomarkers. A plethora of data repositories specialized in ncRNAs have been developed over the years using publicly available high-throughput data from next-generation sequencing and other approaches, that cover various facets of ncRNA research like basic and functional annotation, expressional profile, structural and molecular changes, and interaction with other biomolecules. Here, we provide a compendium of the current ncRNA databases relevant to cardiovascular research.

Highlights

  • Cardiovascular diseases (CVD) are ailments of the heart and the circulatory system and include a variety of highly prevalent disorders such as coronary artery disease (CAD), atherosclerosis (AS), atrial fibrillation (AF), ischemic heart failure (IHF), and congenital heart disease (CHD)

  • Previous reviews have listed long non-coding RNAs (lncRNAs) databases associated with CVDs, the most recent of these being in 2016 [21,22,23,24]

  • This lncRNA is conserved in nature, seen in mice (Mhrt), where they have been shown to serve as a potential biomarker for cardiac hypertrophy and heart failure [13,14,15,25,26]

Read more

Summary

Introduction

Cardiovascular diseases (CVD) are ailments of the heart and the circulatory system and include a variety of highly prevalent disorders such as coronary artery disease (CAD), atherosclerosis (AS), atrial fibrillation (AF), ischemic heart failure (IHF), and congenital heart disease (CHD). There is a growing interest in deciphering the role of non-coding RNAs in disease causality, progression, and therapeutic targeting. To satisfy this growing interest, over 200 databases have been created. Previous reviews have listed lncRNA databases associated with CVDs, the most recent of these being in 2016 [21,22,23,24]. In this age of fast-paced genomic discoveries, it is important to periodically assess the repositories for updates and extended functionalities. We have used some prominent ncRNAs related to CVDs as examples to investigate the salient features in each of these repositories

Noncoding RNA Databases
NONCODE V5
CVDncR
CARDIO-LNCRNAs
Other Resources
Findings
Future Perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call